Bahl & Gaynor’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.6M Buy
554,616
+117,639
+27% +$12.1M 0.27% 95
2025
Q4
$46.4M Buy
436,977
+15,166
+4% +$1.76M 0.23% 93
2025
Q3
$53.6M Buy
421,811
+133,585
+46% +$15.9M 0.27% 90
2025
Q2
$35.3M Buy
288,226
+37,161
+15% +$4.24M 0.18% 103
2025
Q1
$25.4M Buy
251,065
+228,064
+992% +$22.3M 0.13% 108
2024
Q4
$2.12M Sell
23,001
-8,627
-27% -$847K 0.01% 201
2024
Q3
$3.06M Sell
31,628
-882
-3% -$79.3K 0.02% 195
2024
Q2
$2.79M Buy
32,510
+14,054
+76% +$1.18M 0.02% 197
2024
Q1
$1.52M Sell
18,456
-152
-0.8% -$11.1K 0.01% 227
2023
Q4
$1.24M Buy
18,608
+55
+0.3% +$3.56K 0.01% 233
2023
Q3
$1.25M Sell
18,553
-258
-1% -$17.7K 0.01% 226
2023
Q2
$1.27M Sell
18,811
-5,665
-23% -$355K 0.01% 230
2023
Q1
$1.32M Buy
24,476
+711
+3% +$41.4K 0.01% 228
2022
Q4
$1.42M Sell
23,765
-6,819
-22% -$371K 0.01% 227
2022
Q3
$1.38M Sell
30,584
-194,794
-86% -$9.74M 0.01% 224
2022
Q2
$10.1M Buy
225,378
+93,095
+70% +$4.78M 0.07% 116
2022
Q1
$7.48M Sell
132,283
-50,934
-28% -$2.66M 0.06% 131
2021
Q4
$9.51M Buy
183,217
+10,963
+6% +$566K 0.05% 127
2021
Q3
$10.3M Sell
172,254
-1,481
-0.9% -$93.2K 0.06% 114
2021
Q2
$10.8M Sell
173,735
-4,768
-3% -$318K 0.07% 111
2021
Q1
$11.6M Buy
178,503
+356
+0.2% +$23.2K 0.07% 103
2020
Q4
$11.7M Buy
178,147
+1,234
+0.7% +$72.6K 0.07% 101
2020
Q3
$9.14M Sell
176,913
-3,580
-2% -$184K 0.06% 108
2020
Q2
$8.89M Buy
180,493
+1,491
+0.8% +$80.5K 0.07% 106
2020
Q1
$9.12M Sell
179,002
-3,142
-2% -$181K 0.08% 103
2019
Q4
$10M Buy
182,144
+5,458
+3% +$296K 0.07% 107
2019
Q3
$8.89M Buy
176,686
+9,440
+6% +$474K 0.06% 110
2019
Q2
$8.43M Buy
167,246
+11,409
+7% +$554K 0.06% 111
2019
Q1
$7.24M Buy
155,837
+34,792
+29% +$1.76M 0.07% 101
2018
Q4
$5.94M Buy
121,045
+29,190
+32% +$1.66M 0.06% 102
2018
Q3
$5.7M Sell
91,855
-24,030
-21% -$1.46M 0.07% 112
2018
Q2
$6.24M Buy
115,885
+1,208
+1% +$60.4K 0.07% 106
2018
Q1
$5.22M Sell
114,677
-90
-0.1% -$3.86K 0.06% 119
2017
Q4
$4.51M Buy
114,767
+43,031
+60% +$1.64M 0.05% 128
2017
Q3
$2.65M Buy
71,736
+8,985
+14% +$320K 0.03% 170
2017
Q2
$2.42M Buy
62,751
+25,481
+68% +$933K 0.03% 169
2017
Q1
$1.27M Buy
37,270
+8,390
+29% +$276K 0.01% 221
2016
Q4
$947K Buy
28,880
+10,320
+56% +$335K 0.01% 250
2016
Q3
$599K Buy
+18,560
New +$601K 0.01% 302
2016
Q1
Sell
-37,666
Closed -$1.04M 415
2015
Q4
$1.04M Sell
37,666
-3,740
-9% -$106K 0.01% 226
2015
Q3
$1.26M Buy
41,406
+6,279
+18% +$219K 0.02% 201
2015
Q2
$1.29M Buy
35,127
+16,171
+85% +$577K 0.02% 213
2015
Q1
$669K Buy
18,956
+6,707
+55% +$230K 0.01% 272
2014
Q4
$375K Buy
+12,249
New +$382K 0.01% 332

Other funds holding EHC